COVID-19 mortality in the UK Biobank cohort: revisiting and evaluating risk factors

被引:0
|
作者
Joshua Elliott
Barbara Bodinier
Matthew Whitaker
Cyrille Delpierre
Roel Vermeulen
Ioanna Tzoulaki
Paul Elliott
Marc Chadeau-Hyam
机构
[1] Imperial College London,Department of Epidemiology and Biostatistics, School of Public Health
[2] St Mary’s Hospital,MRC Centre for Environment and Health
[3] Norfolk Place,UMR LEASP
[4] Imperial College,Department of Hygiene and Epidemiology
[5] Royal Surrey County Hospital,Institute for Risk Assessment Sciences (IRAS)
[6] Université de Toulouse III,undefined
[7] UPS,undefined
[8] Inserm,undefined
[9] University of Ioannina Medical School,undefined
[10] Utrecht University,undefined
来源
关键词
COVID-19 mortality; SARS-CoV-2; Prospective cohort; UK biobank; Risk factor;
D O I
暂无
中图分类号
学科分类号
摘要
Most studies of severe/fatal COVID-19 risk have used routine/hospitalisation data without detailed pre-morbid characterisation. Using the community-based UK Biobank cohort, we investigate risk factors for COVID-19 mortality in comparison with non-COVID-19 mortality. We investigated demographic, social (education, income, housing, employment), lifestyle (smoking, drinking, body mass index), biological (lipids, cystatin C, vitamin D), medical (comorbidities, medications) and environmental (air pollution) data from UK Biobank (N = 473,550) in relation to 459 COVID-19 and 2626 non-COVID-19 deaths to 21 September 2020. We used univariate, multivariable and penalised regression models. Age (OR = 2.76 [2.18–3.49] per S.D. [8.1 years], p = 2.6 × 10–17), male sex (OR = 1.47 [1.26–1.73], p = 1.3 × 10–6) and Black versus White ethnicity (OR = 1.21 [1.12–1.29], p = 3.0 × 10–7) were independently associated with and jointly explanatory of (area under receiver operating characteristic curve, AUC = 0.79) increased risk of COVID-19 mortality. In multivariable regression, alongside demographic covariates, being a healthcare worker, current smoker, having cardiovascular disease, hypertension, diabetes, autoimmune disease, and oral steroid use at enrolment were independently associated with COVID-19 mortality. Penalised regression models selected income, cardiovascular disease, hypertension, diabetes, cystatin C, and oral steroid use as jointly contributing to COVID-19 mortality risk; Black ethnicity, hypertension and oral steroid use contributed to COVID-19 but not non-COVID-19 mortality. Age, male sex and Black ethnicity, as well as comorbidities and oral steroid use at enrolment were associated with increased risk of COVID-19 death. Our results suggest that previously reported associations of COVID-19 mortality with body mass index, low vitamin D, air pollutants, renin–angiotensin–aldosterone system inhibitors may be explained by the aforementioned factors.
引用
收藏
页码:299 / 309
页数:10
相关论文
共 50 条
  • [1] COVID-19 mortality in the UK Biobank cohort: revisiting and evaluating risk factors
    Elliott, Joshua
    Bodinier, Barbara
    Whitaker, Matthew
    Delpierre, Cyrille
    Vermeulen, Roel
    Tzoulaki, Ioanna
    Elliott, Paul
    Chadeau-Hyam, Marc
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2021, 36 (03) : 299 - 309
  • [2] PREEXISTING COMORBIDITIES PREDICTING COVID-19 AND MORTALITY IN THE UK BIOBANK COMMUNITY COHORT
    Atkins, Janice
    Masoli, Jane
    Delgado, Joao
    Pilling, Luke
    Kuo, Chia-Ling
    Kuchel, George
    Melzer, David
    INNOVATION IN AGING, 2021, 5 : 342 - 343
  • [3] Preexisting Comorbidities Predicting COVID-19 and Mortality in the UK Biobank Community Cohort
    Atkins, Janice L.
    Masoli, Jane A. H.
    Delgado, Joao
    Pilling, Luke C.
    Kuo, Chia-Ling
    Kuchel, George A.
    Melzer, David
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2020, 75 (11): : 2224 - 2230
  • [4] Chronic pain and COVID-19 hospitalisation and mortality: a UK Biobank cohort study
    Hastie, Claire E.
    Foster, Hamish M. E.
    Jani, Bhautesh D.
    O'Donnell, Catherine A.
    Ho, Frederick K.
    Pell, Jill P.
    Sattar, Naveed
    Katikireddi, Srinivasa V.
    Mair, Frances S.
    Nicholl, Barbara I.
    PAIN, 2023, 164 (01) : 84 - 90
  • [5] SLEEP HEALTH TRAITS AND COVID-19: MORTALITY RISK FROM THE UK BIOBANK
    Zheng, Xi
    Ulsa, Ma Cherrysse
    Li, Peng
    Gao, Lei
    Hu, Kun
    SLEEP, 2021, 44 : A273 - A273
  • [6] Obesity and risk of COVID-19: analysis of UK biobank
    Yates, Thomas
    Razieh, Cameron
    Zaccardi, Francesco
    Davies, Melanie J.
    Khunti, Kamlesh
    PRIMARY CARE DIABETES, 2020, 14 (05) : 566 - 567
  • [7] Obesity, walking pace and risk of severe COVID-19 and mortality: analysis of UK Biobank
    Yates, Thomas
    Razieh, Cameron
    Zaccardi, Francesco
    Rowlands, Alex, V
    Seidu, Samuel
    Davies, Melanie J.
    Khunti, Kamlesh
    INTERNATIONAL JOURNAL OF OBESITY, 2021, 45 (05) : 1155 - 1159
  • [8] Obesity, walking pace and risk of severe COVID-19 and mortality: analysis of UK Biobank
    Thomas Yates
    Cameron Razieh
    Francesco Zaccardi
    Alex V. Rowlands
    Samuel Seidu
    Melanie J. Davies
    Kamlesh Khunti
    International Journal of Obesity, 2021, 45 : 1155 - 1159
  • [9] Vitamin D and COVID-19 infection and mortality in UK Biobank
    Claire E. Hastie
    Jill P. Pell
    Naveed Sattar
    European Journal of Nutrition, 2021, 60 : 545 - 548
  • [10] Cardiovascular disease and mortality sequelae of COVID-19 in the UK Biobank
    Raisi-Estabragh, Zahra
    Cooper, Jackie
    Salih, Ahmed
    Raman, Betty
    Lee, Aaron Mark
    Neubauer, Stefan
    Haryey, Nicholas C.
    Petersen, Steffen E.
    HEART, 2023, 109 (02) : 119 - 126